InsidersTradesSigma
Explore the full record of transactions filed by Stuart Gander, Chief Executive Officer. Director active across 2 companies, notably Q-linea AB (publ). In total, 2 disclosures have been logged. Activity tracked since 15 May 2025. The latest transaction was disclosed on 9 June 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
2 of 2 declarations
Stuart Gander is the CEO of Q-linea AB, an innovative company in the medical technology field. As CEO, he is responsible for the strategic direction of the company and the management of its daily operations. His leadership is essential in guiding Q-linea towards its growth and innovation objectives. The company focuses on developing advanced diagnostic solutions.